Celldex Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $5.8M | 146k | 39.66 |
| 2023-09-30 | $3.9M | 144k | 27.53 |
| 2023-06-30 | $5.8M | 172k | 33.93 |
| 2023-03-31 | $3.9M | 109k | 35.98 |
| 2022-12-31 | $5.2M | 117k | 44.57 |
| 2022-09-30 | $4.1M | 145k | 28.11 |
| 2022-06-30 | $2.6M | 97k | 26.96 |
| 2022-03-31 | $7.0M | 207k | 34.06 |
| 2021-12-31 | $5.4M | 140k | 38.64 |
| 2021-09-30 | $2.1M | 40k | 54.00 |
| 2021-06-30 | $730k | 22k | 33.45 |
| 2021-03-31 | $1.1M | 55k | 20.61 |
| 2020-12-31 | $9.0k | 500 | 18.00 |
| 2020-09-30 | $13k | 866 | 15.01 |
| 2020-06-30 | $0 | 2 | 0.00 |
| 2019-09-30 | $0 | 26 | 0.00 |
| 2019-06-30 | $10k | 3.9k | 2.55 |
| 2019-03-31 | $45k | 9.1k | 4.93 |